Sebastian Zeiner, Rishi P Kothari, Mallika Reddy, Nicholas V Mendez, Garrett R Roll, Hillary J Braun, Michael P Bokoch, Kerstin Kolodzie, Oliver Kimberger, Matthieu Legrand, Dieter Adelmann
{"title":"肝移植的高BMI:血液制品使用和术后结果的回顾性单中心分析。","authors":"Sebastian Zeiner, Rishi P Kothari, Mallika Reddy, Nicholas V Mendez, Garrett R Roll, Hillary J Braun, Michael P Bokoch, Kerstin Kolodzie, Oliver Kimberger, Matthieu Legrand, Dieter Adelmann","doi":"10.1016/j.ajt.2025.08.018","DOIUrl":null,"url":null,"abstract":"<p><p>Obesity, generally defined as high body mass index (BMI), is increasingly prevalent in liver transplant recipients, but its impact on perioperative management is still not understood. This study aimed to examine intraoperative transfusion as a marker of surgical complexity, alongside blood loss, ventilation duration, and intensive care unit length of stay. We conducted a retrospective single-center analysis of adult liver transplant recipients between June 1, 2012, and March 31, 2024. Data were extracted from electronic medical records and stratified by BMI to compare demographics, clinical characteristics, intraoperative variables, and postoperative outcomes. Among 1444 recipients, patients with a BMI of ≥40 kg/m<sup>2</sup> required significantly more units of blood products (median, 20 units; IQR, 12-32 units) than normal/overweight patients (median, 12 units; IQR, 6-20 units; P < .001). They had greater blood loss, longer ventilation times, and extended intensive care unit stays (all P < .001). This is the first study to assess granular intraoperative data on blood product use, acute kidney injury, and extubation in liver transplant recipients with a BMI of ≥40 kg/m<sup>2</sup>. It shows that a BMI of ≥40 kg/m<sup>2</sup> is linked to increased perioperative resource utilization and longer hospital stays. Importantly, patients with a BMI of ≥40 kg/m<sup>2</sup> have equivalent long-term outcomes after liver transplant. BMI should be used with extreme caution in candidacy decisions.</p>","PeriodicalId":123,"journal":{"name":"American Journal of Transplantation","volume":" ","pages":""},"PeriodicalIF":8.2000,"publicationDate":"2025-08-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"High body mass index at liver transplantation: A retrospective single-center analysis of blood product utilization and postoperative outcomes.\",\"authors\":\"Sebastian Zeiner, Rishi P Kothari, Mallika Reddy, Nicholas V Mendez, Garrett R Roll, Hillary J Braun, Michael P Bokoch, Kerstin Kolodzie, Oliver Kimberger, Matthieu Legrand, Dieter Adelmann\",\"doi\":\"10.1016/j.ajt.2025.08.018\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Obesity, generally defined as high body mass index (BMI), is increasingly prevalent in liver transplant recipients, but its impact on perioperative management is still not understood. This study aimed to examine intraoperative transfusion as a marker of surgical complexity, alongside blood loss, ventilation duration, and intensive care unit length of stay. We conducted a retrospective single-center analysis of adult liver transplant recipients between June 1, 2012, and March 31, 2024. Data were extracted from electronic medical records and stratified by BMI to compare demographics, clinical characteristics, intraoperative variables, and postoperative outcomes. Among 1444 recipients, patients with a BMI of ≥40 kg/m<sup>2</sup> required significantly more units of blood products (median, 20 units; IQR, 12-32 units) than normal/overweight patients (median, 12 units; IQR, 6-20 units; P < .001). They had greater blood loss, longer ventilation times, and extended intensive care unit stays (all P < .001). This is the first study to assess granular intraoperative data on blood product use, acute kidney injury, and extubation in liver transplant recipients with a BMI of ≥40 kg/m<sup>2</sup>. It shows that a BMI of ≥40 kg/m<sup>2</sup> is linked to increased perioperative resource utilization and longer hospital stays. Importantly, patients with a BMI of ≥40 kg/m<sup>2</sup> have equivalent long-term outcomes after liver transplant. BMI should be used with extreme caution in candidacy decisions.</p>\",\"PeriodicalId\":123,\"journal\":{\"name\":\"American Journal of Transplantation\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":8.2000,\"publicationDate\":\"2025-08-27\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"American Journal of Transplantation\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1016/j.ajt.2025.08.018\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"SURGERY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"American Journal of Transplantation","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.ajt.2025.08.018","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"SURGERY","Score":null,"Total":0}
引用次数: 0
摘要
肥胖,通常被定义为高BMI,在肝移植受者中越来越普遍,但其对围手术期管理的影响仍不清楚。这项研究考察了术中输血作为手术复杂性的标志,以及失血、通气时间和重症监护病房的住院时间。我们对2012年6月1日至2024年3月31日期间的成人肝移植受者进行了回顾性单中心分析。数据从电子病历中提取,并按体重指数(BMI)分层,以比较人口统计学、临床特征、术中变量和术后结果。在1444名接受血液治疗的患者中,BMI≥40的患者需要的血液制品单位(中位数:20单位,IQR: 12-32)明显多于正常/超重患者(中位数:12单位,IQR: 6-20, p < 0.001)。患者失血量较大,通气时间较长,ICU住院时间延长(p < 0.001)。这是第一个评估BMI≥40的肝移植受者术中血液制品使用、急性肾损伤和拔管的颗粒数据的研究。BMI≥40与围手术期资源利用率增加和住院时间延长有关。重要的是,BMI≥40的患者在肝移植后具有相同的长期预后。在决定候选人资格时,应极其谨慎地使用BMI。
High body mass index at liver transplantation: A retrospective single-center analysis of blood product utilization and postoperative outcomes.
Obesity, generally defined as high body mass index (BMI), is increasingly prevalent in liver transplant recipients, but its impact on perioperative management is still not understood. This study aimed to examine intraoperative transfusion as a marker of surgical complexity, alongside blood loss, ventilation duration, and intensive care unit length of stay. We conducted a retrospective single-center analysis of adult liver transplant recipients between June 1, 2012, and March 31, 2024. Data were extracted from electronic medical records and stratified by BMI to compare demographics, clinical characteristics, intraoperative variables, and postoperative outcomes. Among 1444 recipients, patients with a BMI of ≥40 kg/m2 required significantly more units of blood products (median, 20 units; IQR, 12-32 units) than normal/overweight patients (median, 12 units; IQR, 6-20 units; P < .001). They had greater blood loss, longer ventilation times, and extended intensive care unit stays (all P < .001). This is the first study to assess granular intraoperative data on blood product use, acute kidney injury, and extubation in liver transplant recipients with a BMI of ≥40 kg/m2. It shows that a BMI of ≥40 kg/m2 is linked to increased perioperative resource utilization and longer hospital stays. Importantly, patients with a BMI of ≥40 kg/m2 have equivalent long-term outcomes after liver transplant. BMI should be used with extreme caution in candidacy decisions.
期刊介绍:
The American Journal of Transplantation is a leading journal in the field of transplantation. It serves as a forum for debate and reassessment, an agent of change, and a major platform for promoting understanding, improving results, and advancing science. Published monthly, it provides an essential resource for researchers and clinicians worldwide.
The journal publishes original articles, case reports, invited reviews, letters to the editor, critical reviews, news features, consensus documents, and guidelines over 12 issues a year. It covers all major subject areas in transplantation, including thoracic (heart, lung), abdominal (kidney, liver, pancreas, islets), tissue and stem cell transplantation, organ and tissue donation and preservation, tissue injury, repair, inflammation, and aging, histocompatibility, drugs and pharmacology, graft survival, and prevention of graft dysfunction and failure. It also explores ethical and social issues in the field.